Daly Richard J
Insider CIK 1635393 · SGYP Director · CUR Chief Executive Officer, Director · CPRX President and CEO, Director · OPNT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 115,283 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,013 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 126,316 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 381,948 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 491,160 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,365,319 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 271,266 | $31.50 | $8.54M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2026-01-05 | 2026-01-06 | 42,105 | — | $0 | 2,618,539 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2026-01-05 | 2026-01-06 | 10,577 | — | $0 | 271,266 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2026-01-05 | 2026-01-06 | 42,105 | — | $0 | 281,843 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 2,660,644 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-29 | 2025-12-30 | 524 | — | $0 | 239,738 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 240,262 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 20,006 | — | $0 | 2,661,978 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-11-21 | 2025-11-24 | 7,872 | — | $0 | 238,928 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 20,006 | — | $0 | 246,800 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 115,283 | — | $0 | 2,681,984 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 381,948 | — | $0 | 2,546,695 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-08-26 | 2025-08-28 | 50,000 | — | $0 | 2,184,753 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-08-26 | 2025-08-28 | 22,970 | $20.62 | $473.6K | 226,794 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-08-26 | 2025-08-28 | 50,000 | $2.24 | $112.0K | 249,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-05-30 | 2025-06-03 | 70,000 | $24.86 | $1.74M | 199,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 2,234,753 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-02-14 | 2025-02-19 | 1,574 | — | $0 | 269,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 271,338 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-01-02 | 2025-01-03 | 42,105 | — | $0 | 2,238,753 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-01-02 | 2025-01-03 | 42,105 | — | $0 | 277,938 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-01-02 | 2025-01-03 | 10,600 | — | $0 | 267,338 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 2,280,858 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 236,157 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-27 | 2024-12-31 | 324 | — | $0 | 235,833 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 60,019 | — | $0 | 2,282,191 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 491,160 | — | $0 | 2,222,172 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-06-04 | 2024-06-05 | 40,000 | — | $0 | 1,731,012 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-06-04 | 2024-06-05 | 17,323 | $15.98 | $276.8K | 234,824 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-06-04 | 2024-06-05 | 40,000 | $4.01 | $160.4K | 252,147 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 1,771,012 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 213,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 1,186 | — | $0 | 212,147 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-01-01 | 2024-01-03 | 210,526 | — | $0 | 1,775,012 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-01-01 | 2024-01-03 | 1,365,319 | — | $0 | 1,564,486 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 199,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 209,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-07 | 2023-12-11 | 60,000 | — | $0 | 200,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-07 | 2023-12-11 | 60,000 | $1.13 | $67.8K | 208,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-05-12 | 2023-05-16 | 50,000 | — | $0 | 260,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-05-12 | 2023-05-16 | 50,000 | $0.79 | $39.5K | 148,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 5,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 5,800 | $20.00 | $116.0K | 2,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 2,000 | $20.00 | $40.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 98,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 4,000 | — | $0 | 314,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 15,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 295,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 94,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-24 | 2022-08-26 | 40,000 | — | $0 | 296,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-24 | 2022-08-26 | 40,000 | $2.53 | $101.2K | 92,666 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-14 | 2022-06-14 | 2,000 | — | $0 | 7,800 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 12,000 | — | $0 | 336,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-01-25 | 2022-01-26 | 50,000 | — | $0 | 324,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-01-25 | 2022-01-26 | 50,000 | $3.35 | $167.5K | 52,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 20,000 | — | $0 | 374,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 354,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 2,666 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-06-15 | 2021-06-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-06-15 | 2021-06-16 | 2,000 | — | $0 | 5,800 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 30,000 | — | $0 | 356,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-28 | 1,333 | — | $0 | 326,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-28 | 1,333 | — | $0 | 1,333 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2020-06-15 | 2020-06-15 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2020-06-15 | 2020-06-15 | 2,000 | — | $0 | 3,800 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 33,500 | — | $0 | 323,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 4,000 | — | $0 | 327,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2019-09-12 | 2020-03-02 | 1,800 | $13.90 | $25.0K | 1,800 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2019-06-12 | 2019-06-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 290,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 265,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2018-06-12 | 2018-06-13 | 5,000 | $15.56 | $77.8K | 5,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 240,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 220,000 | SEC↗ |
| CUR Neuralstem, Inc. | A Award deriv | 2017-11-07 | 2017-11-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2017-06-28 | 2017-06-30 | 62,500 | — | $0 | 189,056 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2017-05-17 | 2017-05-18 | 7,500 | $4.00 | $30.0K | 23,312 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2017-02-24 | 2017-02-27 | 2,591 | $3.86 | $10.0K | 15,812 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2017-01-25 | 2017-01-27 | 2,841 | $3.52 | $10.0K | 13,221 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 200,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 170,000 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2016-12-23 | 2016-12-30 | 32,259 | $0.31 | $10.0K | 134,939 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2016-11-25 | 2016-11-28 | 35,715 | $0.28 | $10.0K | 102,680 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2016-10-25 | 2016-10-27 | 35,715 | $0.28 | $10.0K | 66,965 | SEC↗ |
| CUR Neuralstem, Inc. | P Buy | 2016-09-23 | 2016-09-26 | 31,250 | $0.32 | $10.0K | 31,250 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-27 | 62,500 | — | $0 | 126,556 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-29 | 62,500 | — | $0 | 126,556 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 115,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 140,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 90,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 70,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2015-07-24 | 2015-07-28 | 19,056 | — | $0 | 64,056 | SEC↗ |